A dynamic nomogram for predicting pathologic complete response to neoadjuvant chemotherapy in locally advanced rectal cancer

被引:2
|
作者
Wang, Guancong [1 ]
Li, Jiasen [2 ]
Huang, Ying [3 ]
Guo, Yincong [1 ]
机构
[1] Fujian Med Univ, Zhangzhou Affiliated Hosp, Dept Colorectal & Anal Surg, Zhangzhou 363000, Peoples R China
[2] Fujian Med Univ, ZhangZhou Affiliated Hosp, Dept Intervent Radiol, Zhangzhou, Peoples R China
[3] Fujian Med Univ, Dept Colorectal Surg, Union Hosp, Fuzhou 350001, Peoples R China
来源
CANCER MEDICINE | 2024年 / 13卷 / 11期
关键词
dynamic nomogram; locally advanced rectal cancer; neoadjuvant chemoradiotherapy; pathological complete response; total mesorectal excision; MUCINOUS ADENOCARCINOMA; TUMOR RESPONSE; ANAL VERGE; CHEMORADIOTHERAPY; THERAPY; RADIOTHERAPY; PROGNOSIS; DISTANCE; MRI;
D O I
10.1002/cam4.7251
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim: To explore the clinical factors associated with pathologic complete response (pCR) for locally advanced rectal cancer (LARC) patients treated with neoadjuvant chemoradiotherapy (nCRT) and develop a web-based dynamic nomogram. Methods: Retrospective analysis of patients with examination confirmed LARC from 2011 to 2022. Patients from the Union Hospital of Fujian Medical University were included as the training cohort (n = 1579) and Zhangzhou Hospital of Fujian Medical University as the external validation cohort (n = 246). Results: In the training cohort, after nCRT, 350 (22.2%) patients achieved pCR. More stomas were avoided in pCR patients (73.9% vs. 69.7%, p = 0.043). After a median follow-up time of 47.7 months (IQR 2-145) shown OS (5-year: 93.7% vs. 81.0%, HR = 0.310, 95%CI: 0.189-0.510, p < 0.001) and DFS (5-year: 91.2% vs. 75.0%, HR = 0.204, 95%CI: 0.216-0.484, p < 0.001) were significantly better among patients with pCR than non-pCR. Multivariable Logistic analysis shown pCR was significantly associated with Pre-CRT CEA (HR = 0.944, 95%CI: 0.921-0.968; p < 0.001), histopathology (HR = 4.608, 95%CI: 2.625-8.089; p < 0.001), Pre-CRT T stage (HR = 0.793, 95%CI: 0.634-0.993; p = 0.043), Pre-CRT N stage (HR = 0.727, 95%CI: 0.606-0.873; p = 0.001), Pre-CRT MRI EMVI (HR = 0.352, 95%CI: 0.262-0.473; p < 0.001), total neoadjuvant therapy (HR = 2.264, 95%CI: 1.280-4.004; p = 0.005). Meanwhile, the online version of the nomogram established in this study was publicized on an open-access website (URL: ). The model predicted accuracy with a C-index of 0.73 (95% CI: 0.70-0.75), with an average C-index of 0.73 for the internal cross validation and 0.78 (95% CI: 0.72-0.83) for the external validation cohort, showing excellent model accuracy. Delong test results showed the model has an important gain value for clinical characteristics to predict pCR in rectal cancer. Conclusions: Patients with pCR had a better prognosis, including OS and DFS, and were independently associated with Pre-CRT CEA, histopathology, Pre-CRT T/N stage, Pre-CRT MRI EMVI, and TNT. A web-based dynamic nomogram was successfully established for clinical use at any time.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Biomarkers Predicting Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer
    Li, Xiaoxian Bill
    Krishnamurti, Uma
    Bhattarai, Shristi
    Ktimov, Sergey
    Reid, Michelle D.
    O'Regan, Ruth
    Aneja, Ritu
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2016, 145 (06) : 871 - 878
  • [32] Predicting Pathologic Complete Response After Neoadjuvant Chemoradiotherapy Based On Deep-Learning Analysis of MRI in Locally Advanced Rectal Cancer
    Kim, E.
    Jang, W. I.
    Yang, K.
    Kim, M. S.
    Yoo, H. J.
    Paik, E. K.
    Moon, S. M.
    Shin, U. S.
    Cho, S. S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E590 - E590
  • [33] Predicting pathologic complete response in locally advanced rectal cancer patients after neoadjuvant therapy: a machine learning model using XGBoost
    Chen, Xijie
    Wang, Wenhui
    Chen, Junguo
    Xu, Liang
    He, Xiaosheng
    Lan, Ping
    Hu, Jiancong
    Lian, Lei
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2022, 37 (07) : 1621 - 1634
  • [34] Can MRI Predict Pathologic Complete Response After Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer?
    Lee, C.
    Le-Tran, V.
    Olimpiadi, Y.
    Zaremba, N.
    Nelson, M.
    Lang, J. E.
    Sener, S. F.
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 : S90 - S90
  • [35] Predicting pathologic response to neoadjuvant chemotherapy in patients with locally advanced breast cancer using multiparametric MRI
    Nannan Lu
    Jie Dong
    Xin Fang
    Lufang Wang
    Wei Jia
    Qiong Zhou
    Lingyu Wang
    Jie Wei
    Yueyin Pan
    Xinghua Han
    BMC Medical Imaging, 21
  • [36] Pathologic response to neoadjuvant treatment in locally advanced rectal cancer and impact on outcome
    Jalilian, Mahshid
    Davis, Sidney
    Mohebbi, Mohammadreza
    Sugamaran, Bhuvana
    Porter, Ian W.
    Bell, Stephen
    Warrier, Satish K.
    Wale, Roger
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2016, 7 (04) : 603 - 608
  • [37] Predicting pathologic response to neoadjuvant chemotherapy in patients with locally advanced breast cancer using multiparametric MRI
    Lu, Nannan
    Dong, Jie
    Fang, Xin
    Wang, Lufang
    Jia, Wei
    Zhou, Qiong
    Wang, Lingyu
    Wei, Jie
    Pan, Yueyin
    Han, Xinghua
    BMC MEDICAL IMAGING, 2021, 21 (01)
  • [38] Predicting pathologic response to neoadjuvant chemotherapy in locally advanced gastric cancer: The establishment of a spectral CT-based nomogram from prospective datasets
    Li, Jing
    Chen, Xuejun
    Xu, Shuning
    Wang, Yi
    Ma, Fei
    Wu, Yue
    Qu, Jinrong
    EJSO, 2024, 50 (04):
  • [39] Effect of neoadjuvant IMRT for locally advanced rectal cancer on toxicity and pathologic response
    David, John
    Jabbour, Salma
    Gresham, Gillian K.
    Deek, Mathew
    Shant, Thomassian
    Robertson, John M.
    Kabolizadeh, Peyman
    Tuli, Richard
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [40] Assessment of biomarker expression in predicting pathologic response to neoadjuvant chemotherapy in patients with locally advanced breast cancer
    Chhieng, David C.
    Rodriguez-Burford, Cristina
    Meleth, Sreelatha
    Grizzle, William E.
    Ferguson, Susan M.
    BREAST JOURNAL, 2007, 13 (05): : 534 - 535